Measured 2026-08-07 · public DNS
Is institutgodinot.fr protected against email spoofing?
No — institutgodinot.fr has no DMARC policy and can be spoofed.
Unchanged since 2026-07-09
Stronger than 0% of major hospitals in France
8% of the sector already enforces p=reject
See the sector barometer →See the whole sector →
F
DMARC
absent
SPF
?all
DKIM
none found
Watch this domain for free
No time to create an account? Leave your email: you’ll be notified if the DMARC configuration of institutgodinot.fr changes (a regression, or a domain still left unprotected).
How to fix it
Thomas, your AI-powered virtual CISO, finds every sender, writes the exact DNS, and walks your domain safely from p=none to p=reject.
What this means
- • No DMARC record published (_dmarc.<domain>). Receivers have no policy to apply.
- • SPF ends with ?all (neutral): provides no effective protection.
- • No DKIM key found on the common selectors (the domain may use non-standard selectors).
History
- 2026-07-09First measurementNo DMARC
About Institut Godinot Site Hopital Robert Debre Du Chu De Reims
Institut Godinot is a cancer treatment centre located in Reims, in northeastern France. It belongs to the national network of comprehensive cancer centres brought together under UNICANCER, which comprises private not-for-profit hospital institutions entirely dedicated to oncology. The establishment is situated on the site of the Robert Debré hospital, which is part of the University Hospital Centre (CHU) of Reims, allowing geographic proximity and coordination of care pathways between the two structures.
The institute's principal mission is the care of patients affected by cancerous pathologies, covering diagnostic, therapeutic and follow-up aspects. Its scope of activity typically extends to treatments through oncological surgery, radiotherapy and chemotherapy, as well as multidisciplinary consultations bringing together several medical specialties. As a comprehensive cancer centre, it is also involved in clinical and translational research, participating in therapeutic trials and contributing to the evolution of oncology practices, in line with national directions set by the UNICANCER network.
The positioning of Institut Godinot is built around complementarity with other health structures in the Grand Est region, particularly the CHU of Reims, allowing a distribution of expertise and technical facilities between general hospital medicine and specialised oncology. This organisation aims to offer a coordinated care pathway to patients in the region, from diagnosis through post-treatment follow-up, drawing on expertise concentrated on cancerous diseases. The establishment also participates in training and teaching missions, in connection with local university institutions.
The website institutgodinot.fr is the institutional site of Institut Godinot and provides information about the establishment, its care offering, its research activities, as well as resources intended for patients and healthcare professionals.